1 Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis [期刊论文]
来源:Chest: The Journal of Circulation, Respiration and Related Systems , 2018
作者:Jamie L. Todd^1,2, Scott M. Palmer^1,2, Laurie Snyder^1,2
关键词:clinical trial;idiopathic pulmonary fibrosis;...
使用许可:CC BY
预览 | 原文链接 | 全文 [ 浏览:20 下载:16 ]